Map Unavailable
Date/Time
Date(s) - 2021/11/25 - 2021/11/26
9:00 am - 5:00 pm
Export to Google Calendar
Price
For price, request the agenda
Categories
Request for event
To ensure that therapies for serious conditions are approved and available to patients as soon as it can be concluded that the therapies’ benefits justify their risks, regulatory agencies have developed specific processes to speed the availability of new therapies, especially when there are no satisfactory alternative therapies, while preserving appropriate standards for safety and effectiveness.
Event Website: CMC Readiness Challenge in case of Expedited Programs for Biotechnological Products MasterClass